Assessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn’s disease in the United States: a claims data analysis-Reference-Cited by-同舟云学术

Assessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn’s disease in the United States: a claims data analysis

Published:2017-01-12 Issue:3 Volume:33 Page:529-536
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Rubin David T.¹,Patel Haridarshan²,Shi Sherry³,Mody Reema⁴

Affiliation:

1. University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA;

2. Immensity Consulting Inc., Chicago, IL, USA;

3. Analysis Group Inc., Montreal, QC, Canada;

4. Global Outcomes Research, Takeda Development Center Americas Inc., Deerfield, IL, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2016.1267616

Reference34 articles.

1. Inflammatory bowel disease: clinical aspects and treatments

2. Crohn’s & Colitis Foundation of America. The facts about inflammatory bowel diseases. Crohn’s and Colitis Foundation. Available at: http://www.ccfa.org/assets/pdfs/updatedibdfactbook.pdf [Last accessed 24 November 2016]

3. Inflammatory Bowel Disease

4. Review article: appropriate use of corticosteroids in Crohn’s disease

5. American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis;Therapeutic Advances in Gastroenterology;2024-01

2. The incidence of remission and indicators of inadequate response to advanced therapy in patients with ulcerative colitis: results from medical charts in the United Kingdom;Current Medical Research and Opinion;2023-04-18

3. Quality of Care in Inflammatory Bowel Disease: the Role of Steroid Assessment Tool (SAT) - a Review;Medicina Moderna - Modern Medicine;2020-09-26

Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1

;Clinical and Experimental Gastroenterology;2020-06

5. Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients;Alimentary Pharmacology & Therapeutics;2019-10-08